Semaglutide Hub · formblends network
The semaglutide reference: how Ozempic, Wegovy, the semaglutide tablets and compounded semaglutide differ, a titration planner built from the label schedules, a units-to-mg converter for vials, the missed-dose rules, a side-effect view from STEP data, and self-pay prices with the date we checked them.
Interactive
Each runs in your browser, shows its formula, and prints a dated assumptions note. Nothing you type leaves the page.
Dated Ozempic, Wegovy and tablet schedules from the label, with a calendar file.
Compounded vial concentration to mL, syringe units and the nearest mark.
The Ozempic 5-day rule, the Wegovy 48-hour rule and the tablet rule, applied to a clock.
STEP and SUSTAIN adverse reaction rates vs placebo, and when they cluster.
NovoCare self-pay prices with dates, and per-mg cost for any vial or box.
Reading
Written for people doing the arithmetic themselves: where the mistakes happen, and how to check your own work.
Compare
Every difference that matters between the two semaglutide injections, from the label: indications and their dates, escalation and maximum dose, missed-dose rules, pen design, adverse reaction rates in their own trials, and self-pay price.
Updated September 4, 2026
Compare
An honest side-by-side from a site whose parent company dispenses compounded semaglutide: regulatory status, what was tested, how the dose is measured, what the label guarantees and a compounded vial does not, and where price fits.
Updated September 4, 2026
Guides
How the planner turns the label escalation schedules for Ozempic, Wegovy, Wegovy tablets, Rybelsus and Ozempic tablets into dated steps, what it refuses to do, and which decisions stay with your prescriber.
Updated September 4, 2026
Guides
Why a compounded semaglutide vial needs arithmetic that a brand pen does not, how the converter turns a concentration and a prescribed dose into syringe units and the nearest mark, and the errors it is built to catch.
Updated September 4, 2026
Guides
The exact missed-dose text from the Ozempic, Wegovy injection and semaglutide tablet labels, why the two injection rules give different answers, and how the helper applies them to your clock.
Updated September 4, 2026
Guides
The adverse reaction tables from the Wegovy and Ozempic labels, the pooled STEP 1 to 3 tolerability analysis, and what the trials say about timing, with the arithmetic that turns a percentage into a personal risk.
Updated September 4, 2026
Browse
Ozempic and Wegovy are the same semaglutide in different pens with different label schedules, maximum doses and missed-dose rules. The tablets (Rybelsus, Ozempic tablets and Wegovy tablets) add a daily routine with a 30-minute fasting window. Compounded semaglutide is none of these: it is not FDA approved, not interchangeable with them, and comes in vials whose concentration changes from fill to fill. Every page on this site says which product it is talking about.
Label facts cite the FDA prescribing information by revision date and DailyMed set id. Trial results cite the PubMed id of the primary publication. Prices cite Novo Nordisk's own price sheet with the date we read it. If a number is not on this site, we could not verify it. Pages carry an updated date and change when the label, the price or the evidence does.
From the FormBlends network
Sister sites